The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Strumentova E.S.

I.I. Mechnikov North-Western State Medical University

Lobzin V.Yu.

I.I. Mechnikov North-Western State Medical University;
S.M. Kirov Military Medical Academy;
Saint-Petersburg State University

Maltsev D.S.

S.M. Kirov Military Medical Academy

Burnasheva M.A.

S.M. Kirov Military Medical Academy

Sergeeva T.V.

Saint-Petersburg State University;
City Hospital of St. Elizabeth the Great Martyr;
Saint-Petersburg State Paediatric Medical University

Buryak A.B.

Saint-Petersburg State University;
City Hospital of St. Elizabeth the Great Martyr

Curcumin-induced increased retinal fluorescence as a new method in the early diagnosis of Alzheimer’s disease

Authors:

Strumentova E.S., Lobzin V.Yu., Maltsev D.S., Burnasheva M.A., Sergeeva T.V., Buryak A.B.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(4‑2): 19‑25

DOI: 10.17116/jnevro202512504219

Read: 877 times

Buy for 300₽
Contact the author
Table of contents

CURCUMIN-INDUCED INCREASED RETINAL FLUORESCENCE AS A NEW METHOD IN THE EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE
CURCUMIN-INDUCED INCREASED RETINAL FLUORESCENCE AS A NEW METHOD IN THE EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE

To cite this article:

Strumentova ES, Lobzin VYu, Maltsev DS, Burnasheva MA, Sergeeva TV, Buryak AB. Curcumin-induced increased retinal fluorescence as a new method in the early diagnosis of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(4‑2):19‑25. (In Russ.)
https://doi.org/10.17116/jnevro202512504219

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
Change of subjective cognitive decline in first-degree rela­tives of patients with Alzheimer’s disease: resu­lts of a 15-year prospective study. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):36-42
A comprehensive study of Alzheimer’s disease biomarkers in plasma and cere­brospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53
Como­rbidity of depression and deme­ntia: epidemiological, biological and therapeutic aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):113-121
The rela­tionship between neuropsychological indi­cators and neuroimaging changes acco­rding to MRI morphometry in patients with Alzheimer’s disease and glaucoma. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):142-152
Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16
The expe­rience of diagnosing Alzheimer’s disease based on the study of cere­brospinal fluid biomarkers. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):91-97
Neurobiological pote­ntial of astragaloside IV and prospects for its use in the treatment of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):7-12
Abstract:

OBJECTIVE

To search for an effective method for early diagnosis of Alzheimer’s disease (AD) and mild cognitive impairment (MCI) of amnestic type using scanning laser ophthalmoscopy as a safe and widely available examination method.

MATERIAL AND METHODS

The study included 45 patients: 20 with AD, 10 with MCI, and 15 healthy control subjects. The patients were examined to visualize amyloid deposition in the retina using a solid lipid food curcumin ligand and a modified scanning laser ophthalmoscope, with a total of 63 observations since not all subjects were eligible for assessment of the retinas of both eyes. All patients underwent a neurological and ophthalmological examination, neuropsychological testing (MMSE, FCSRT, Clock Drawing test), brain MRI for visual assessment of atrophic changes (using global cortical atrophy scales, GCA and the medial temporal lobe atrophy, MTA), as well as confocal scanning laser ophthalmoscopy at two timepoints before and during curcumin administration. A semi-automated calculation of the area increase multiplicity (S) and the number (N) of particles with peak brightness (PPB) was performed.

RESULTS

In patients with AD, the following findings were obtained after taking curcumin: NPPB 167% [129; 258] (p=0.1) and SPPB 198% [148; 230] (p=0.007); MCI: NPPB 123% [114; 157] (p=0.15) and SPPB 129% [110; 140] (p=0.08).

CONCLUSION

The results indicate an increased deposition of beta-amyloid protein in the retina in patients with AD and expand the possibilities of its early diagnosis.

Keywords:

Alzheimer’s disease
mild cognitive impairment
beta-amyloid protein
eye
retina
curcumin
scanning laser ophthalmoscopy

Authors:

Strumentova E.S.

I.I. Mechnikov North-Western State Medical University

Lobzin V.Yu.

I.I. Mechnikov North-Western State Medical University;
S.M. Kirov Military Medical Academy;
Saint-Petersburg State University

Maltsev D.S.

S.M. Kirov Military Medical Academy

Burnasheva M.A.

S.M. Kirov Military Medical Academy

Sergeeva T.V.

Saint-Petersburg State University;
City Hospital of St. Elizabeth the Great Martyr;
Saint-Petersburg State Paediatric Medical University

Buryak A.B.

Saint-Petersburg State University;
City Hospital of St. Elizabeth the Great Martyr

Received:

28.01.2025

Accepted:

31.01.2025

Close metadata

References:

  1. Alekseeva TM, Abdulaev ShK, Abritalin EYu, et al. Neurodegenerative diseases: pathogenesis, clinic, diagnostics, therapy. St. Petersburg: SpetsLit Publishing House. 2024. (In Russ.).
  2. Tkacheva ON. Clinical recommendations: cognitive disorders in the elderly and senile. O.N. Tkacheva, N.N. Yakhno, N.G. Neznanov, et al. M.: Ministry of Health of the Russian Federation. 2020. (In Russ.).
  3. Frolova EV, Emelin AY, Lobzin VY. Cognitive impairment in old age: a guide for physicians. Moscow: LLC «GEOTAR-Media». 2023. (In Russ.).
  4. Yakhno NN, Tsarkova ON, Gavrilova SI, et al. P Integrated interdisciplinary and interdepartmental program of prevention, early detection, diagnosis and treatment of cognitive disorders in the elderly and senile. Russian Journal of Geriatric Medicine. 2022;1:6-16. (In Russ.). https://doi.org/10.37586/2686-8636-1-2022-6-16
  5. Tadokoro K, Yamashita T, Kimura S, et al. Retinal Amyloid Imaging for Screening Alzheimer’s Disease. J Alzheimers Dis. 2021;83(2):927-934.  https://doi.org/10.3233/JAD-210327
  6. Bogolepova AN, Makhnovich EV, Kovalenko EA, et al. Potential biomarkers of early diagnosis of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(9):7-14. (In Russ.). https://doi.org/10.17116/jnevro20221220917
  7. Gulieva RN. Retinal changes in Alzheimer’s disease. Vestnik Ophthalmologii. 2020;136(3):74-78. (In Russ.). https://doi.org/10.17116/oftalma202013603174
  8. Lobzin VYu, Maltsev DS, Strumentova ES, et al. Ophthalmological markers of Alzheimer’s disease. Medical alphabet. 2022;(1):47-53. (In Russ.). https://doi.org/10.33667/2078-5631-2022-1-47-53
  9. Strumentova ES, Lobzin VYu, Maltsev DS, et al. Optical coherence tomography with angiography in the diagnosis of Alzheimer’s disease. Proceedings of the Russian Military Medical Academy. 2023;42(4):403-411. (In Russ.). https://doi.org/10.17816/rmmar492301
  10. den Haan J, Hart de Ruyter FJ, Lochocki B, et al. No difference in retinal fluorescence after oral curcumin intake in amyloid-proven AD cases compared to controls. Alzheimers Dement (Amst). 2022;14(1):e12347. https://doi.org/10.1002/dad2.12347
  11. den Haan J, Morrema THJ, Rozemuller AJ, et al. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics. Acta Neuropathol Commun. 2018;6(1):75.  https://doi.org/10.1186/s40478-018-0577-2
  12. Dumitrascu OM, Lyden PD, Torbati T, et al. Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline. Alzheimers Dement (Amst). 2020;12(1):e12109. https://doi.org/10.1002/dad2.12109
  13. Dumitrascu OM, Doustar J, Fuchs DT, et al. Retinal peri-arteriolar versus peri-venular amyloidosis, hippocampal atrophy, and cognitive impairment: exploratory trial. Acta Neuropathol Commun. 2024;12(1):109.  https://doi.org/10.1186/s40478-024-01810-2
  14. Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535-562.  https://doi.org/10.1016/j.jalz.2018.02.018
  15. Kang S, Kim M, Kim H, et al. Enhancement of Solubility, Stability, Cellular Uptake, and Bioactivity of Curcumin by Polyvinyl Alcohol. Int J Mol Sci. 2024;25(11):6278. https://doi.org/10.3390/ijms25116278
  16. Lv H, Wang Y, Yang X, et al. Application of curcumin nanoformulations in Alzheimer’s disease: prevention, diagnosis and treatment. Nutr Neurosci. 2023;26(8):727-742.  https://doi.org/10.1080/1028415X.2022.2084550
  17. Zoi V, Galani V, Lianos GD, et al. The Role of Curcumin in Cancer Treatment. Biomedicines. 2021;9(9):1086. https://doi.org/10.3390/biomedicines9091086
  18. Koronyo Y, Biggs D, Barron E, et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease. JCI Insight. 2017;2(16):e93621. https://doi.org/10.1172/jci.insight.93621
  19. Koronyo Y, Rentsendorj A, Mirzaei N, et al. Retinal pathological features and proteome signatures of Alzheimer’s disease. Acta Neuropathol. 2023;145(4):409-438.  https://doi.org/10.1007/s00401-023-02548-2
  20. Tomeh MA, Hadianamrei R, Zhao X. A Review of Curcumin and Its Derivatives as Anticancer Agents. Int J Mol Sci. 2019;20(5):1033. https://doi.org/10.3390/ijms20051033
  21. Ferguson JJA, Abbott KA, Garg ML. Anti-inflammatory effects of oral supplementation with curcumin: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2021;79(9):1043-1066. https://doi.org/10.1093/nutrit/nuaa114
  22. Petersen R, Touchon J. Consensus on mild cognitive impairment. Research and practice in AD. Mater. EADS-ADCS joint meeting. 2005;10:24-32. 
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.